![](/img/cover-not-exists.png)
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis
Gooderham, Melinda J., Forman, Seth B., Bissonnette, Robert, Beebe, Jean S., Zhang, Weidong, Banfield, Chris, Zhu, Linda, Papacharalambous, Jocelyne, Vincent, Michael S., Peeva, ElenaLanguage:
english
Journal:
JAMA Dermatology
DOI:
10.1001/jamadermatol.2019.2855
Date:
October, 2019
File:
PDF, 307 KB
english, 2019